X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215458
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210093
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211979
https://www.reuters.com/article/us-acasti-pharma-study/acastis-krill-oil-derived-drug-fails-late-stage-study-shares-tumble-idUSKBN1ZC10A?feedType=RSS&feedName=healthNews
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211355
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210107
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207420
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203893
http://www.in-pharmatechnologist.com/Ingredients/Acasti-strengthens-IP-position-for-krill-derived-Lovaza-rival
https://www.pharmacompass.com/pdf/news/amneals-generic-omega-3-acid-ethyl-esters-approved-in-us-1449058763.pdf
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/05/all-for-one-and-one-for-all-nope-court-rejects-fdas-one-to-many-complex-mixture-nce-exclusivity-deci.html
Market Place
Share 
